Sartorius Stedim Biotech S.A. (DIM.PA)
EUR 188.3
(1.02%)
EUR 188.3
(1.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 484.5 Million EUR | -51.32% |
| 2022 | 995.2 Million EUR | 45.65% |
| 2021 | 683.3 Million EUR | 44.83% |
| 2020 | 471.8 Million EUR | 42.1% |
| 2019 | 332.02 Million EUR | 10.59% |
| 2018 | 300.23 Million EUR | 35.42% |
| 2017 | 221.7 Million EUR | -1.87% |
| 2016 | 225.91 Million EUR | 22.43% |
| 2015 | 184.53 Million EUR | 53.3% |
| 2014 | 120.37 Million EUR | 18.77% |
| 2013 | 101.34 Million EUR | 16.22% |
| 2012 | 87.2 Million EUR | 22.55% |
| 2011 | 71.15 Million EUR | 18.8% |
| 2010 | 59.89 Million EUR | 23.21% |
| 2009 | 48.61 Million EUR | 44.12% |
| 2008 | 33.73 Million EUR | 142.45% |
| 2007 | 13.91 Million EUR | -94.33% |
| 2006 | 245.24 Million EUR | 10.7% |
| 2005 | 221.52 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 70.8 Million EUR | -26.95% |
| 2024 Q1 | 113.2 Million EUR | 148.25% |
| 2024 Q2 | 112.8 Million EUR | -0.35% |
| 2023 Q2 | 185.7 Million EUR | 9.88% |
| 2023 Q1 | 169 Million EUR | -21.83% |
| 2023 Q4 | 45.6 Million EUR | -40.7% |
| 2023 Q3 | 76.9 Million EUR | -58.59% |
| 2023 FY | 484.5 Million EUR | -51.32% |
| 2022 FY | 995.2 Million EUR | 45.65% |
| 2022 Q4 | 216.2 Million EUR | -25.32% |
| 2022 Q1 | 348.8 Million EUR | 32456.22% |
| 2022 Q2 | 294.5 Million EUR | -15.57% |
| 2022 Q3 | 289.5 Million EUR | -1.7% |
| 2021 FY | 683.3 Million EUR | 44.83% |
| 2021 Q1 | 197.5 Million EUR | 31.1% |
| 2021 Q4 | -1.07 Million EUR | -100.47% |
| 2021 Q3 | 229.8 Million EUR | 5.95% |
| 2021 Q2 | 216.9 Million EUR | 9.82% |
| 2020 FY | 471.8 Million EUR | 42.1% |
| 2020 Q2 | 105.5 Million EUR | 3.23% |
| 2020 Q1 | 102.2 Million EUR | 4.52% |
| 2020 Q4 | 150.65 Million EUR | 3.33% |
| 2020 Q3 | 145.8 Million EUR | 38.2% |
| 2019 Q1 | 80.1 Million EUR | -6.12% |
| 2019 FY | 332.02 Million EUR | 10.59% |
| 2019 Q4 | 97.78 Million EUR | 16.83% |
| 2019 Q3 | 83.7 Million EUR | -3.9% |
| 2019 Q2 | 87.1 Million EUR | 8.74% |
| 2018 Q3 | 72.6 Million EUR | 0.69% |
| 2018 Q2 | 72.1 Million EUR | 25.17% |
| 2018 Q1 | 57.6 Million EUR | -32.53% |
| 2018 Q4 | 85.32 Million EUR | 17.53% |
| 2018 FY | 300.23 Million EUR | 35.42% |
| 2017 Q3 | 50.9 Million EUR | -12.09% |
| 2017 Q4 | 85.37 Million EUR | 67.73% |
| 2017 Q1 | 57.8 Million EUR | -14.4% |
| 2017 FY | 221.7 Million EUR | -1.87% |
| 2017 Q2 | 57.9 Million EUR | 0.17% |
| 2016 Q1 | 50.8 Million EUR | -5.38% |
| 2016 FY | 225.91 Million EUR | 22.43% |
| 2016 Q4 | 67.52 Million EUR | 7.0% |
| 2016 Q3 | 63.1 Million EUR | 6.05% |
| 2016 Q2 | 59.5 Million EUR | 17.13% |
| 2015 FY | 184.53 Million EUR | 53.3% |
| 2015 Q1 | 41.3 Million EUR | 14.5% |
| 2015 Q4 | 53.68 Million EUR | -4.47% |
| 2015 Q3 | 56.2 Million EUR | 22.44% |
| 2015 Q2 | 45.9 Million EUR | 11.14% |
| 2014 Q3 | 30.3 Million EUR | -0.66% |
| 2014 FY | 120.37 Million EUR | 18.77% |
| 2014 Q1 | 24.5 Million EUR | -15.39% |
| 2014 Q2 | 30.5 Million EUR | 24.49% |
| 2014 Q4 | 36.07 Million EUR | 19.05% |
| 2013 Q4 | 28.95 Million EUR | 24.82% |
| 2013 FY | 101.34 Million EUR | 16.22% |
| 2013 Q1 | 21.7 Million EUR | -22.6% |
| 2013 Q2 | 30.6 Million EUR | 41.01% |
| 2013 Q3 | 23.2 Million EUR | -24.18% |
| 2012 Q4 | 28.03 Million EUR | 0.0% |
| 2012 Q2 | 21.3 Million EUR | 0.0% |
| 2012 FY | 87.2 Million EUR | 22.55% |
| 2011 FY | 71.15 Million EUR | 18.8% |
| 2011 Q2 | 15.4 Million EUR | 0.0% |
| 2010 FY | 59.89 Million EUR | 23.21% |
| 2010 Q2 | 14.8 Million EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | 48.61 Million EUR | 44.12% |
| 2008 FY | 33.73 Million EUR | 142.45% |
| 2007 FY | 13.91 Million EUR | -94.33% |
| 2006 FY | 245.24 Million EUR | 10.7% |
| 2005 FY | 221.52 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Crossject Société Anonyme | -11.8 Million EUR | 4205.932% |
| Safe Orthopaedics SA | -5.96 Million EUR | 8226.468% |
| Spineway SA | -9.03 Million EUR | 5463.073% |
| Amplitude Surgical SA | 13.24 Million EUR | -3559.089% |
| EssilorLuxottica Société anonyme | 3.17 Billion EUR | 84.745% |
| bonyf N.V. | -39.89 Thousand EUR | 1214565.601% |